Eri Banno

Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder

FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions

The Firmicutes/Bacteroidetes ratio of the human gut microbiota is associated with prostate enlargement

FGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib